KIRYOUNG KIM: Open Payments
NPI 1679125629 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 9 payments from 6 companies in 2025. Trend: 2023 $105 · 2024 $247 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $53 |
| Incyte Corporation | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: TECVAYLI, Stivarga.
Industry payments across MD — which companies pay providers there.
